X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (189077) 189077
Book Review (23400) 23400
Publication (11571) 11571
Newsletter (2861) 2861
Newspaper Article (1953) 1953
Book Chapter (621) 621
Conference Proceeding (446) 446
Government Document (305) 305
Book / eBook (221) 221
Magazine Article (208) 208
Dissertation (140) 140
Web Resource (33) 33
Paper (14) 14
Trade Publication Article (13) 13
Data Set (9) 9
Journal / eJournal (4) 4
Streaming Video (4) 4
Presentation (3) 3
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (174729) 174729
humans (161384) 161384
male (79310) 79310
female (73316) 73316
middle aged (59337) 59337
aged (50958) 50958
oncology (50863) 50863
animals (48310) 48310
adult (41551) 41551
cancer (38693) 38693
mice (31696) 31696
immunohistochemistry (25293) 25293
prognosis (23587) 23587
antigens (23097) 23097
expression (21540) 21540
abridged index medicus (19772) 19772
tumors (19632) 19632
aged, 80 and over (19608) 19608
prostate cancer (19311) 19311
pathology (16752) 16752
immunology (15607) 15607
carcinoma (15598) 15598
research (15220) 15220
prostate-specific antigen - blood (15184) 15184
immunotherapy (14944) 14944
cell line, tumor (14708) 14708
antigen (13624) 13624
neoplasm staging (13473) 13473
prostatic neoplasms - pathology (13226) 13226
antigens, neoplasm - immunology (12659) 12659
antigens, neoplasm - analysis (11531) 11531
metastasis (11519) 11519
diagnosis (11486) 11486
analysis (11468) 11468
care and treatment (11043) 11043
urology & nephrology (10929) 10929
surgery (10389) 10389
retrospective studies (10382) 10382
cell biology (10332) 10332
tumor cells, cultured (10266) 10266
neoplasms - immunology (10151) 10151
treatment outcome (9657) 9657
prostate-specific antigen (9601) 9601
biomarkers, tumor - analysis (9284) 9284
apoptosis (9012) 9012
biomarkers, tumor - blood (8951) 8951
proteins (8860) 8860
prostatic neoplasms - blood (8759) 8759
survival (8702) 8702
health aspects (8669) 8669
hematology (8609) 8609
adolescent (8594) 8594
prostatic neoplasms - diagnosis (8459) 8459
gene expression (8412) 8412
chemotherapy (8397) 8397
risk factors (8269) 8269
flow cytometry (8261) 8261
cells (8225) 8225
biopsy (7983) 7983
cell line (7959) 7959
biochemistry & molecular biology (7737) 7737
t-lymphocytes - immunology (7710) 7710
medicine, research & experimental (7679) 7679
antigens, neoplasm (7669) 7669
follow-up studies (7630) 7630
lymphocytes (7561) 7561
time factors (7356) 7356
article (7337) 7337
gene expression regulation, neoplastic (7267) 7267
sensitivity and specificity (7225) 7225
breast cancer (7065) 7065
biomarkers, tumor - metabolism (7039) 7039
therapy (6940) 6940
dendritic cells (6939) 6939
neoplasm transplantation (6889) 6889
cell proliferation (6528) 6528
mice, inbred balb c (6461) 6461
diagnosis, differential (6455) 6455
predictive value of tests (6452) 6452
medicine & public health (6385) 6385
immunoenzyme techniques (6310) 6310
melanoma (6261) 6261
genetic aspects (6199) 6199
medicine (6142) 6142
carcinoembryonic antigen - analysis (6092) 6092
antigens, neoplasm - metabolism (6062) 6062
breast-cancer (6015) 6015
t cells (5996) 5996
neoplasm metastasis (5991) 5991
breast neoplasms - pathology (5956) 5956
mice, inbred c57bl (5950) 5950
research article (5943) 5943
adenocarcinoma - pathology (5901) 5901
adenocarcinoma (5873) 5873
neoplasms - therapy (5871) 5871
antigens, neoplasm - genetics (5856) 5856
disease progression (5774) 5774
antibodies, monoclonal (5744) 5744
child (5742) 5742
disease-free survival (5732) 5732
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (165) 165
Online Resources - Online (28) 28
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (179945) 179945
Japanese (3359) 3359
Chinese (3108) 3108
German (2273) 2273
French (1854) 1854
Russian (1539) 1539
Spanish (792) 792
Italian (535) 535
Polish (488) 488
Czech (149) 149
Hungarian (119) 119
Korean (112) 112
Portuguese (100) 100
Danish (66) 66
Norwegian (57) 57
Swedish (57) 57
Dutch (52) 52
Romanian (50) 50
Croatian (46) 46
Bulgarian (44) 44
Hebrew (44) 44
Serbian (32) 32
Finnish (28) 28
Slovak (28) 28
Ukrainian (25) 25
Turkish (17) 17
Lithuanian (6) 6
Greek (4) 4
Bosnian (3) 3
Persian (3) 3
Arabic (2) 2
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 2, pp. 270 - 273
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, pp. e0145754 - e0145754
Background High-grade serous ovarian and endometrial cancers are the most lethal female reproductive tract malignancies worldwide. In part, failure to treat... 
CA-125 | MULTIDISCIPLINARY SCIENCES | EPITHELIAL OVARIAN-CANCER | Endometrial Neoplasms - mortality | Humans | Middle Aged | Ovarian Neoplasms - mortality | Genital Neoplasms, Female - drug therapy | DNA, Neoplasm - blood | Endometrial Neoplasms - genetics | Adult | Female | Neoplasm Recurrence, Local - blood | Ovarian Neoplasms - drug therapy | Genital Neoplasms, Female - genetics | CA-125 Antigen - blood | Ovarian Neoplasms - blood | Genital Neoplasms, Female - blood | Mutation - genetics | Breast Neoplasms - drug therapy | Biomarkers, Tumor - blood | Genital Neoplasms, Female - mortality | Exome - genetics | Breast Neoplasms - genetics | Breast Neoplasms - blood | Breast Neoplasms - mortality | Endometrial Neoplasms - drug therapy | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Endometrial Neoplasms - blood | Physiological aspects | Prognosis | Biological markers | Genital cancer | Tumors | Plasma | Scanning | Ovarian carcinoma | Medical services | Fallopian tube | Cancer therapies | Ovarian cancer | Gene sequencing | Computed tomography | Surgery | Quality | Imaging | Bioindicators | Endometrium | Deoxyribonucleic acid--DNA | DNA probes | Gynecology | Breast cancer | Patients | Survival | Obstetrics | Medicine | Lead time | Chemotherapy | Surveillance | Womens health | Biomarkers | Diagnostic systems | Mutation | Reproductive system | Uterine cancer | Peritoneum | Cancer | Index Medicus | Deoxyribonucleic acid | DNA | Computer aided tomography
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Abstract Purpose To assess preliminary safety and efficacy results of the anti-programmed cell death ligand-1 (anti-PD-L1) durvalumab in combination with... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, pp. e0179501 - e0179501
Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully... 
CD2 | THERAPY | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | GENES | IMMUNOMODULATORY ACTION | MECHANISMS | MOLECULES | SGI-110 | Colonic Neoplasms - genetics | DNA Methylation - immunology | DNA, Neoplasm - metabolism | Humans | Antigens, Neoplasm - biosynthesis | Ovarian Neoplasms - pathology | Male | Colonic Neoplasms - metabolism | Testicular Neoplasms - pathology | Ovarian Neoplasms - genetics | Colonic Neoplasms - immunology | Female | Ovarian Neoplasms - metabolism | Caco-2 Cells | Antigens, Neoplasm - genetics | Testicular Neoplasms - genetics | Antigens, Neoplasm - immunology | Testicular Neoplasms - metabolism | Antigen Presentation - genetics | DNA Methylation - genetics | Testicular Neoplasms - immunology | Animals | Colonic Neoplasms - pathology | DNA, Neoplasm - immunology | Mice | DNA, Neoplasm - genetics | Ovarian Neoplasms - immunology | Colon cancer | Tumor antigens | Physiological aspects | Development and progression | Genetic aspects | Research | Methylation | Ovarian cancer | Therapy | Biotechnology | Animal models | Ovarian carcinoma | CD58 antigen | Antigen processing | Genomes | Tissues | Cancer therapies | Immunotherapy | Surgery | Cell cycle | DNA methylation | Inhibition | Colon | Drug dosages | Deoxyribonucleic acid--DNA | Immune system | Antigen presentation | Antigens | Tumor cells | Melanoma | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Patients | Immune systems | Medicine | Inhibitors | Epigenetics | Solid tumors | Tumors | Cancer | Index Medicus | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | TRANSGENIC MOUSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIANDROGEN RESISTANCE | CONDITIONAL MOUSE MODEL | AURORA KINASE | METASTATIC PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | N-MYC | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin | Index Medicus
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2008, Volume 15, Issue 12, pp. 3433 - 3439
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 822 - 835
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 8/2007, Volume 56, Issue 8, pp. 1173 - 1182
The programmed death-1 (PD-1)/B7-H1 (also called PD-L1) pathway negatively regulates T cell activation and has been suggested to play an important role in... 
Urothelial cancer | Biomedicine | Immunology | B7-H1/PD-L1 | Costimulation | T cell | Oncology | Cancer Research | Antitumor immunity | PD-1 | BLADDER-CANCER | DENDRITIC CELLS | PROGRAMMED DEATH-1 | urothelial cancer | TISSUE INFILTRATING LYMPHOCYTES | IMMUNOLOGY | antitumor immunity | POTENTIAL MECHANISM | RENAL-CELL CARCINOMA | CD8(+) T-CELLS | costimulation | ONCOLOGY | PD-L1 | B7 FAMILY | B7-H1 | EXPRESSION | Carcinoma, Transitional Cell - mortality | Prognosis | Antigens, CD - biosynthesis | Humans | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Kidney Pelvis - chemistry | Ureteral Neoplasms - pathology | Male | Kidney Neoplasms - chemistry | Antigens, CD - genetics | Antigens, CD - analysis | Kidney Neoplasms - surgery | Urinary Bladder Neoplasms - pathology | Female | Neoplasm Proteins - genetics | Kidney Pelvis - surgery | Urinary Bladder Neoplasms - mortality | B7-H1 Antigen | Neoplasm Proteins - biosynthesis | Ureteral Neoplasms - chemistry | Neoplasm Recurrence, Local | Proportional Hazards Models | Kidney Pelvis - pathology | Immunophenotyping | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Carcinoma, Transitional Cell - chemistry | Survival Analysis | Antigens, CD - physiology | Kidney Neoplasms - pathology | Neoplasm Proteins - analysis | Urinary Bladder Neoplasms - chemistry | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Lymphocytes, Tumor-Infiltrating - immunology | Cancer | Index Medicus
Journal Article